Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

ClinicalTrials.gov ID: NCT00992017

Public ClinicalTrials.gov record NCT00992017. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Both pregnant women and people infected with HIV are at increased risk of viral infection, including influenza infection. Pregnant women infected with HIV may be at particular risk of infection from the new H1N1 influenza virus. This study tested the safety and immunogenicity of an H1N1 influenza vaccine in pregnant women infected with HIV.

Study identification

NCT ID
NCT00992017
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
130 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 39 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Nov 5, 2021

2009 – 2010

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Usc La Nichd Crs Alhambra California 91803 —
University of California, UC San Diego CRS La Jolla California 92093-0672 —
Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach California 90806 —
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California 90095-1752 —
Univ. of California San Francisco NICHD CRS San Francisco California 94143 —
Univ. of Colorado Denver NICHD CRS Aurora Colorado 80045 —
Washington Hosp. Ctr. NICHD CRS Washington D.C. District of Columbia 20010 —
South Florida CDTC Ft Lauderdale NICHD CRS Fort Lauderdale Florida 33316 —
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209 —
Pediatric Perinatal HIV Clinical Trials Unit CRS Miami Florida 33136 —
USF - Tampa NICHD CRS Tampa Florida 33606 —
Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago Illinois 60612 —
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS Chicago Illinois 60614-3393 —
Tulane Univ. New Orleans NICHD CRS New Orleans Louisiana 70112 —
Johns Hopkins Univ. Baltimore NICHD CRS Baltimore Maryland 21287 —
Children's Hosp. of Boston NICHD CRS Boston Massachusetts 02115 —
Boston Medical Center Ped. HIV Program NICHD CRS Boston Massachusetts 02118 —
WNE Maternal Pediatric Adolescent AIDS CRS Worcester Massachusetts 01605 —
Rutgers - New Jersey Medical School CRS Newark New Jersey 07103 —
Metropolitan Hosp. NICHD CRS New York New York 10029 —
Columbia IMPAACT CRS New York New York 10032 —
SUNY Stony Brook NICHD CRS Stony Brook New York 11794-8111 —
Bronx-Lebanon CRS The Bronx New York 10457 —
Jacobi Med. Ctr. Bronx NICHD CRS The Bronx New York 10461 —
DUMC Ped. CRS Durham North Carolina 27710 —
The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia Pennsylvania 19104 —
St. Jude Children's Research Hospital CRS Memphis Tennessee 38105-3678 —
Texas Children's Hospital CRS Houston Texas 77030-2399 —
Seattle Children's Research Institute CRS Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00992017, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00992017 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →